Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversityArticle Published on 2020-11-012023-07-12 Journal: Virology [Category] SARS, [키워드] COVID19 Phylogenetic structure Phylogeny SARS-CoV-2 [DOI] 10.1016/j.virol.2020.08.010 PMC 바로가기
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis이란 다발성 경화증 환자의 코로나19 감염, 입원, 사망 비율 평가Article Published on 2020-11-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] SARS, 진단, [키워드] addition asked clinic Complication Computed tomography Contact correlation COVID-19 COVID-19 diagnosis COVID-19 infection COVID-19 symptoms COVID19 death demographic characteristics Diagnosis died disease drug evaluate evaluated General population highlight Hospitalization immunosuppressive drug incidence of COVID-19 increase increasingly lung medication Multiple multiple sclerosis Nurse Patient patients PCR polymerase chain positive rate of infection risk risk reduction rituximab severity of COVID-19 social distancing the disease these symptom Two patient underlying disease was performed were infected were recorded [DOI] 10.1016/j.msard.2020.102472 PMC 바로가기 [Article Type] Article
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsSARS-CoV-2 스파이크 단백질 변이체에 의한 중화 항체로부터의 탈출Research Article Published on 2020-10-282022-09-10 Journal: eLife [Category] MERS, SARS, 변종, 진단, [키워드] activate addressed Administered Analysis anti-SARS-CoV-2 antibodies antibody antibody combination antibody-based therapies antibody-based therapy Blood blood plasma cause Cell cells changed chimeric circulating Combination convalescent plasma coronavirus COVID-19 COVID19 creating effective vaccine Effective vaccines Effectiveness effort elicited eLife Epitopes escape evade Frequency functional Genome Health HIV host cells Human human cells human population human populations immune immune response immune system in some individual infect Infection Influenza kill Laboratory limit low frequencies maintain monoclonal antibodies monoclonal antibody mutant mutant virus mutate mutated Mutation N-terminal domain natural infection neutralize Neutralizing antibodies neutralizing antibody neutralizing epitopes New coronavirus Patient Population populations Prevent produced Prophylactic Proteins question RBD Receptor-binding domain Recovered COVID-19 patients reporter Research SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genomes SARS-CoV-2 S SARS-CoV-2 S protein SARS-CoV-2 spike protein SARS-CoV-2 variant selected Sequencing Spike protein Spike proteins Structure structures target the antibody the disease the receptor-binding domain the SARS-CoV-2 the spike protein the strongest therapeutic Therapies treated Trigger vaccination Vaccine Vaccines variant Viral protein Viral proteins virus virus mutation virus particle virus particles viruses VSV were infected [DOI] 10.7554/eLife.61312 PMC 바로가기 [Article Type] Research Article
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturationArticle Published on 2020-10-272022-10-04 Journal: Nature Communications [Category] MERS, SARS, 변종, [키워드] antibody affinity Betacoronavirus bind binding binding affinity competing complex COVID-19 pandemic COVID19 determine effective epitope human ACE2 receptor induce infected with SARS-CoV-2 maturation mechanism monoclonal antibody motif Mutation neutralization Neutralizing neutralizing antibody overlap Patient Receptor binding domain reduction in responsible reveal SARS-CoV-2 the S1 subunit Treatment Vaccine viral infection virus X-ray X-ray crystallography [DOI] 10.1038/s41467-020-19231-9 PMC 바로가기 [Article Type] Article
Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatmentReview Published on 2020-10-222022-10-31 Journal: Channels [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Analysis can be used caused cellular Combination coronavirus COVID-19 pandemic COVID19 Diagnosis drug drug target effective Evidence exhibited expand HCV hepatitis C highlight identify immune responses in viral include Inflammation ion channels ion homeostasis knowledge Medicine offer patients peg-IFN Perspective prevention of COVID-19 pulmonary system reduction reveal Ritonavir SARS-CoV-2 similarity Symptom target the disease Treatment treatment approach treatments for COVID-19 Via Viral load viruses [DOI] 10.1080/19336950.2020.1837439 PMC 바로가기 [Article Type] Review
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Research Published on 2020-10-222022-10-31 Journal: Eurosurveillance [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome antibody Blood blood donor can be used collected Control coronavirus COVID19 demonstrated detect detection determine diagnosed Donor Epidemic geographical distribution Infection marker microneutralisation assay neutralising antibody number of sample outbreak pandemic performed progression pseudotyped SARS-CoV-2 virus remained Result SARS-CoV-2 Scottish sera serological serology Serosurvey significantly surveillance, Scotland symptomatic individual the epidemic the SARS-CoV-2 United Kingdom was used [DOI] 10.2807/1560-7917.ES.2020.25.42.2000685 PMC 바로가기 [Article Type] Research
COVID-19: Need for Equitable and Inclusive Pandemic Response FrameworkIX. Report from India: Responses to COVID-19 Published on 2020-10-192022-10-30 Journal: International journal of health services : plannin [Category] COVID-19, MERS, SARS, [키워드] adopted Appropriate clinical diagnoses Community component contributed COVID-19 COVID-19 case COVID-19 outbreak COVID19 Critical develop disease effective effective interventions Epidemic facilitate framework Government Health health information identify Infectious disease management measure Mitigation pandemic public health Regular Research response Surveillance therapeutic were used [DOI] 10.1177/0020731420967630 PMC 바로가기 [Article Type] IX. Report from India: Responses to COVID-19
Risk Factors and Mental Health Promotion Strategies in Children During COVID-19Public Health Published on 2020-10-152022-10-31 Journal: Frontiers in Public Health [Category] Coronavirus, MERS, SARS, [키워드] children COVID-19 COVID19 Factor mental health promotion Risk factors Strategies Strategy [DOI] 10.3389/fpubh.2020.580720 PMC 바로가기 [Article Type] Public Health
Estimating the Percentage of a Population Infected with SARS-CoV-2 Using the Number of Reported Deaths: A Policy Planning ToolArticle Published on 2020-10-132022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] Accuracy approach coronavirus country COVID19 death deaths dependent on estimate Fatality rate help immune IMPROVE Infection less Low- and middle-income countries magnitude number percentage Planning Policy Population population immunity populations Prevalence public health authority reported SARS-CoV-2 SARS-CoV-2 antibody Sero-prevalence serology Vaccines widespread [DOI] 10.3390/pathogens9100838 PMC 바로가기 [Article Type] Article
Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric orthopaedic patients during the COVID19 pandemic and post-pandemic period in ItalyCommentary Published on 2020-10-082022-10-29 Journal: Italian Journal of Pediatrics [Category] COVID-19, [키워드] activity Care children Contagion COVID-19 COVID-19 outbreak COVID19 drastic exceptional Healthcare provider hospitals impacted Italian Italy limit maintain management pandemic Patient pediatric Pediatric Orthopaedics recommendation recommendations routine care routine clinical practice SARS-CoV-2 Society Spread System Traumatology Treatment [DOI] 10.1186/s13052-020-00911-7 PMC 바로가기 [Article Type] Commentary